Pfizer - before the bell

[stockguru]

(02-08-2022, 09:49 AM)Scooterd Wrote:

(02-08-2022, 09:32 AM)stockguru Wrote: PFE is too dependent on Covid. That's what the street sees them as. And as Covid numbers come down they wont be able to repeat those numbers.

I will be jumping on their 10am call.

Phama is all about Pipeline and growth,
And Pfizer has a very Robust pipeline in and of itself (regardless of partnerships and future Bolt on Acquisitions) -

At Present

• 27 new drugs in Phase 1 trials
  
• 25 new drugs in Phase 2 trials
  
• 27 new drugs in Phase 3 trials
  
• 10 Registration
  
• 89Total
  

You can download their Pipeline here  - https://www.pfizer.com/science/drug-product-pipeline

Their present product list here (too many to count)  - https://www.pfizer.com/products/product-list

- Scoot

Doesn't matter about PFE. Its what the street see's them as. Nothing has changed in 10 years with this company. At least from the Streets point of view. If you take out Covid this is a $40 stock.